Lithium - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Lithium

Description:

Daniel Sabin. Sean Toyooka. Micah Walter. Brian Zacker. Bipolar Disorder. Manic depressive illness characterized by dramatic mood swings, episodes of ... – PowerPoint PPT presentation

Number of Views:4689
Avg rating:3.0/5.0
Slides: 23
Provided by: trung6
Category:
Tags: lithium | sabin

less

Transcript and Presenter's Notes

Title: Lithium


1
Lithium
  • Presented By
  • Cory Bradley
  • Claire Evangelista
  • Nicole Goff
  • Ayla Johnson
  • Robert Leontyev
  • Phung Nguyen
  • Roy Pfund
  • Daniel Sabin
  • Sean Toyooka
  • Micah Walter
  • Brian Zacker

2
Bipolar Disorder
  • Manic depressive illness characterized by
    dramatic mood swings, episodes of mania and
    depression
  • Affects 5.7 million adults (2.8 of the
    population) have bipolar
  • One more fun bipolar fact to fill up this
    slide

3
Symptoms
  • Mania symptoms increased energy, euphoric mood,
    extreme irritability, racing thoughts, little
    sleep needed, aggressive behavior, and delusion
    of grandeur
  • Depression Symptoms decreased energy, empty
    mood, hopelessness, restlessness, feelings of
    guilt, thoughts of suicide, loss of interests,
    and change in appetite
  • Causes of Bipolar are unknown

4
Treatments
  • Anticonvulsants Valproate and carbamazepine,
  • Lamotrigine, Gabapentin, and Topiramate are
    still being studied for the treatment of bipolar
  • Atypical Antipsychotics Clozapine, Olanzapine,
    Risperidone, Quetiapine, and Ziprasidone are
    still being studied for the treatment of bipolar
  • Psychosocial treatment helpful in providing
    support, education, and guidance for the patients
    and family
  • Antidepressants can be used during depressive
    stage
  • Other treatments Electroconvulsive therapy,
    herbal or natural supplements (St. Johns wort)
    and omega-3 fatty acids
  • Lithium Most often prescribed and most effective

5
Pharmacology
  • Mechanism not well understood
  • Alters sodium transport, may interfere with ion
    exchange/nerve conduction
  • Enhances uptake of NE, 5HT into the synaptosomes,
    ? their action
  • ?release of NE from synaptic vesicles and
    inhibits prod. of cAMP
  • May produce a transitory diuresis (?in Na, K
    excretion)
  • Other possible mechanisms to help to regulate
    mood
  • alteration of gene expression and the
  • non-competitive inhibition of Inositol
    Monophosphatase
  • Lithium ion deactivates the GSK-3B enzyme.
  • Glutamate is the key factor in understanding how
    lithium works

6
Dose and Cost comparison
  • Prices are from drugstore.com
  • Average medication cost .80 per day or 24 per
    month for a dose
  • of 900mg/day

7
Most common Li side effects
  • Postabsorbtive SE
  • GI discomfort
  • Nausea
  • Vertigo
  • Muscle weakness
  • A dazed feeling
  • Common and persistent SE (May not justify a
    decrease in dose)
  • Fine tremor of the hands
  • Fatigue
  • Thirst
  • Polyuria
  • Nephrogenic Diabetes Insipidus

Lacy CF, Armstrong LL, Goldman MP, Lance LL. 
Drug Information Handbook, 13th ed.  Hudson,
Ohio, Lexi-Comp, Inc. 2005  902-903.
http//www.mentalhealth.com/drug/p30-l02.htmlHea
d_
8
General Li cautions
  • Li toxicity is closely related to serum lithium
    concentrations.
  • Dont exceed 1.5 mmol/L to avoid serious adverse
    reactions and lithium intoxication.
  • Mild SE can present even when serum lithium
    concentrations are below 1 mmol/L, right near the
    blank of therapeutic range.
  • Patients might experience lithium accumulation
    during initial therapy which can increase to
    toxic concentrations quickly.
  • Watch the geriatric patients. They might have
    lower renal clearance and are more susceptible
    to adverse effects even when lithium levels are
    in therapeutic range.

http//www.mentalhealth.com/drug/p30-l02.htmlHead
_
9
Progression from dose to toxicity
  • In patients with normal renal clearance the toxic
    manifestations occur in a fairly predictable
    sequence related to serum lithium concentrations.
  • The usually transient gastrointestinal symptoms
    are the earliest side effects to occur. A mild
    degree of fine tremor of the hands may present
    throughout therapy. Development of a rough tremor
    should be a warning sign.
  • Thirst and polyuria may be followed by increased
    drowsiness, ataxia, tinnitus and blurred vision,
    indicating early intoxication.
  • As intoxication progresses the following
    manifestations may be encountered confusion,
    increasing disorientation, muscle twitchings,
    hyperreflexia, nystagmus, seizures, diarrhea,
    vomiting, and eventually coma and death.

http//www.rxlist.com/cgi/generic/lithium.htm http
//www.mentalhealth.com/drug/p30-l02.htmlHead_
10
Li side effects
  • Common side effects
    Involuntary
    quivering
    Excessive thirst

  • Nausea
  • Diarrhea
  • Problems with bladder control
  • Frequent Urination
  • Infrequent side effects
  • Abnormal heart rhythm
  • Feeling faint
  • Weight gain
  • Trouble breathing
  • Increase in WBC
  • Acne
  • Rash
  • Bloating
  • Rare side effects
  • Depression
  • Pseudotumor cerebri
  • Hair loss
  • Dry skin
  • Pain in digits, hands or feet.
  • Any disturbance of the senses
  • affecting the limbs.
  • Edema in hands, feet or limbs in general.
  • Hoarseness
  • Over Excitement

www.Rxlist.com/drugs/drug-1448-LithiumCarbonateM
isc.aspx?drugid1448drugnameLithiumCarbonateMi
scpagenumber6 http//www.revoptom.com/HANDBOOK/S
ECT53a.HTM Lacy CF, Armstrong LL, Goldman MP,
Lance LL.  Drug Information Handbook, 13th ed. 
Hudson, Ohio, Lexi-Comp, Inc. 2005 
902-903 http//www.mentalhealth.com/drug/p30-l02.h
tmlHead_
11
Li side effects During Pregnancy
  • Pregnancy Risk Factor D (1st and 2nd trimesters)
  • Cardiac Malformations (Ebsteins anomaly)
  • Still used, but only at lowest doses possible
    with monitoring.
  • ?Clr and ?distribution into RBC can lead to
    subtheraputic levels if dose not increased.
  • Condition reverses upon childbirth, results in
    toxicity if dose not decreased.

Lacy CF, Armstrong LL, Goldman MP, Lance LL. 
Drug Information Handbook, 13th ed.  Hudson,
Ohio, Lexi-Comp, Inc. 2005  902-903.
http//www.mentalhealth.com/drug/p30-l02.htmlHea
d_ www.mayoclinic.org/.../ebsteins-anomaly-lg.jpg
12
Drug Interactions
  • Diuretics ? Li clearance. ? Li blood
    concentrations
  • Distal tubule
    Hydrochlorothiazide
  • Proximal tubule Acetazolamide
  • Loop diuretics such as
    furosemide and bumetanide have mixed reports
  • NSAIDs ? Li clearance, ? blood Li
    concentrations
  • Ibuprofen, naproxen
  • ACE Inhibitors May ? the risk of developing
    lithium toxicity
  • ? LI clearance ? Li
    blood concentrations
  • Enalapril, Lisinopril
  • Angiotensin Receptor Blockers Inhibits
    elimination
  • Losartan, Valsartan
  • SSRI ? the amount of lithium that is lost into
    the urine
  • serotonergic hyperarousal syndrome. Fluoxetine,
    sertraline, and fluvoxamine
  • Caffeine appears to reduce serum lithium
    concentrations

13
Pharmacokinetics
  • ABSORPTION
  • Lithium is absorbed 100 in all forms and
    therefore has a bioavailability of 1.
  • Total absorption occurs over a period of 6-8
    hours to peak concentration at 2-3 hours.
  • DISTRIBUTION
  • Lithium follows a 2 compartment model
  • The distribution occurs over 6-10 hours
  • Do not sample during this time
  • Lithium is not protein bound

14
Pharmacokinetics
  • METABOLISM
  • There is none
  • EXRETION
  • Lithium is almost completely eliminated renally
    and excreted in urine
  • More then 95
  • If clearance is reduced from renal dysfunction,
    dosing should be reduced.
  • During acute onset of mania, clearance may
    increase by up to 50
  • The t1/2 is 24 hours and testing for levels in
    the blood should be taken after this time.

15
How to determine dosing?
  • First find Clearance (L/day)
  • Normal Cl 0.288 (CrCl)
  • Acute mania Cl 0.432 (CrCl)
  • Target Css is between 0.6-0.8 mEq/L
  • In acute mania, target can go up to 0.8-1.2 mEq/L

16
Dosing
  • Dose/interval (in mmol/day) Css Cl/F
  • Css target conc.
  • Cl calculated from last slide.
  • F always 1
  • Will come out in mmol/day
  • Must convert by multiplying in 300mg/8.12 mmol
    Li

17
How to determine initial dosing?
  • Test using Perry Method.
  • Using a dose of 600-1500mg
  • Test serum concentration at 12 and 36 hours
  • Find the k value
  • K (ln C 12hr ln C 36hr) / 24
  • Using the k find the accumulation ratio R
  • R 1/ (1 e k(tau) )

18
Test dosing-Perry Method, cont
  • Css R C12 hours
  • Using the new concentration at steady state at
    time t12, find new dose
  • Dnew Cssnew Dold/ Cssold

19
Equations Summary
  • Cl 0.288 (CrCl)
  • Cl 0.432 (CrCl)
  • Dose/interval Css Cl/F
  • K (ln C 12hr ln C 36hr) / 24
  • R 1/ (1 e k(tau)
  • Css R C12 hours
  • Dnew Cssnew Dold/ Cssold

20
Example Kinetic Problems
  • Patient Parameters
  • Age, weight, height, CrCl lt- whatever we need
  • Then Link to excel sheet and input these
    parameters

21
Sources
  • Bauer, Larry A. Applied Clinical
    Pharmacokinetics. 2001. pg 658
  • Brunton, Laurence L. Goodman Gilmans The
    Pharmacological Basis of Therapeutics 11th Ed.
    2006.Pg 488

22
  • References
  • Geddes, John Burgess, Sally et al. Long-term
    Lithium Therapy for Bi-polar Disorder Systematic
    Review and Meta-Analysis of Randomized Controlled
    Trials. Amer. Jour. Of Psych. 2004, 1612, pp
    217-222
  • http//www.biopsychiatry.com/lithobid.jpg-site of
    lithobid pic
Write a Comment
User Comments (0)
About PowerShow.com